Bone-vascular calcium balance

Vitamin K2 (MK-7)

MK-7 reliably improves vitamin K status biomarkers, while BMD and fracture endpoints remain mixed across trials.

Evidence Level B

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Consistent biomarker improvement with variable hard-outcome signal
Safety
Low Risk

Can interact with vitamin K-antagonist anticoagulants.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
90-200 mcg (MK-7)
Timing
Daily with meals containing fat
Protocol Duration in Studies
12+ weeks with ongoing maintenance

Often paired with vitamin D3 to support calcium direction toward bone and away from vascular tissue.

Best Fit Profiles

  • vitamin D protocols
  • bone and artery support stacks

Source Links